Search Within

Gunjan Lalitchandra Shah

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (45)
  2. Journal Article (20)
  3. Research Letter (3)
Groups
  1. Advanced Practice Providers (68)
  2. Bone Marrow Transplant (68)
  3. Center for Hematologic Malignancies (68)
  4. Department of Medicine (68)
  5. Hematologic Malignancies, Division of (68)
  6. Survivorship Research (68)

More Groups

People
  1. Sergio Giralt (52)
  2. Miguel-Angel Perales (39)
  3. Sean Devlin (39)
  4. Michael Scordo (38)
  5. Craig Sauter (30)
  6. Parastoo Dahi (27)

More People

Years
  1. 2024 (3)
  2. 2023 (7)
  3. 2022 (7)
  4. 2021 (9)
  5. 2020 (12)
  6. 2019 (13)

More Years

Publications
  1. Blood (28)
  2. Biology of Blood and Marrow Transplantation (13)
  3. Blood Advances (5)
  4. Bone Marrow Transplantation (4)
  5. Transplantation and Cellular Therapy (4)
  6. Clinical Lymphoma, Myeloma and Leukemia (2)

More Publications

Publishers
  1. American Society of Hematology (33)
  2. Elsevier Inc. (19)
  3. Nature Publishing Group (4)
  4. Taylor & Francis Group (2)
  5. Adis International Ltd (1)
  6. American Association for Cancer Research (1)

More Publishers

Results (68)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Resource utilization within 30 days of car T cells for hematologic malignancies
    Meeting Abstract

    Shah, G.; Park, J.; Sauter, C.; Duck, E.; Halton, E.; Batlevi, C.; Palomba, M. L.; Younes, A.; Geyer, M.; Smith, E.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  • Dysgeusia is associated with higher melphalan pharmacokinetic levels and results in poorer caloric intake and worse symptom burden after autologous stem cell transplantation for multiple myeloma
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Preston, E. V.; Rodriguez, N.; Lin, A.; Maloy, M.; Mastrogiacomo, B.; Carlow, D.; Schofield, R.; Knezevic, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Resource utilization early after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J. H.; Sauter, C. S.; Duck, E.; Halton, E.; Palomba, M. L.; Batlevi, C. L.; Younes, A.; Geyer, M. B.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Continuous mobile wearable bio-monitoring of newly diagnosed multiple myeloma patients undergoing initial chemotherapy
    Meeting Abstract

    Tavitian, E.; Mastey, D.; Salcedo, M.; Zarski, A.; Chansakul, A.; Diab, V.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Impact of pre-transplant rituximab on efficacy of revaccination of lymphoma patients after autologous hematopoietic stem cell transplantation
    Meeting Abstract

    Preston, E. V.; Palazzo, M. A.; Seier, K.; Devlin, S. M.; Giralt, S.; Scordo, M.; Dahi, P. B.; Matasar, M. J.; Moskowitz, C. H.; Sauter, C. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Unlocking the complex flavors of dysgeusia after hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Shah, G. L.; Peled, J. U.; Preston, E. V.; Buchan, M. L.; Epstein, J. B.; Barasch, A.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Revaccination after autologous hematopoietic stem cell transplantation is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance
    Journal Article

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Maloy, M.; Kenny, S.; Hassoun, H.; Korde, N. S.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Disease progression is main barrier to allogeneic hematopoietic stem cell transplantation (HCT) in patients with newly diagnosed and relapsed acute leukemia
    Meeting Abstract

    Preston, E. V.; Chinapen, S.; Borrill, T.; Davis, E.; Shaffer, B. C.; Tamari, R.; Jakubowski, A. A.; Perales, M. A.; Ponce, D. M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Rituximab use, immune reconstitution, and vaccination after ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Preston, E. V.; Malard, F.; Seier, K.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Palazzo, M.; Smith, K.; Maslak, P.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save